Systemic Autoimmune Diseases & Immunodeficiencies - Nelson Flashcards

1
Q

What are autoimmune diseases?

A

Immune-mediated inflammatory disease in which tissue and cell injury are due to immune reactions to self-antigens (autoimmunity).

  • May be mediated by:
    • autoantibodies
    • immune complexes
    • T-lymphocytes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the key underlying immune defect in autoimmune diseases?

A

loss of self-tolerance

(phenomenon of unresponsiveness to an individual’s own antigens)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Does the presence of autoantibodies always indicate the presence of autoimmune disease?

A

NO

Presence of autoantibodies does not always indicate the presence of autoimmune disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two key factors that combined lead to autoimmune disease?

A
  • Inheritance of susceptible genes
    • interfere with self-tolerance
  • Environmental triggers
    • infections
    • tissue injury
    • inflammation
    • activation of self-reactive lymphocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some of the ways that infections can cause autoimmunity?

A
  • Up-regulate the expression of co-stimulators on APC’s
  • Molecular Mimicry
    • offending organism expresses antigens that have the same amino acid sequence of self-antigens
  • Viruses (EBV, HIV) - cause polyclonal B-Lymphocyte activation
  • Tissue injury due to the infection releases self-antigens
    • structurally alter self-antigens
  • Hygiene Hypothesis
    • as infections become better controlled, autoimmune diseases are increasing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the typical clinical course of untreated autoimmune disease?

A
  • Initially may be directed at a specific organ or tissue
    • resulting in organ specific disease
  • May become directed at widespread antigens
    • resulting in systemic or generalized disease; tend to be progressive.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the underlying pathologic mechanism of systemic lupus erythematosis (SLE)?

A
  • Fundamental defect: failure of mechanisms to maintain self-tolerance.
    • pathogenesis related to presence of susceptibility genes + environmental triggers (UV light, estrogen, certain medications)
  • formation of multiple autoantibodies (anti-nuclear antibodies or ANA’s)
    • cause injury by depositing immune complexes
    • bind antibodies to various cells and tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the potential complication of the presence of anti-phospholipid antibodies in SLE?

A
  • May produce a false positive syphilis test
  • Can prolong the partial thromboplastin time (lupus anticoagulant)
  • Secondary Anti-phospholipid Antibody Syndrome:
    • Hypercoagulable state
    • Venous and arterial thrombosis
    • Spontaneous miscarriages
    • Cerebral ischemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why can SLE involve multiple organ systems?

A
  • Most of the systemic lesions of SLE are caused by immune complex deposition
    • Type III Hypersensitivity
  • Loss of self-tolerance and persistence of nuclear antigens leads to the formation of antigen-antibody complexes
    • deposited in the tissues → injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some of the key pathologic and clinical features seen in SLE when involving the skin, kidney, joints, and hematologic system?

A
  • Skin: Erythema in light exposed areas, IC deposition at dermoepidermal junctions
  • Kidney: IC deposition in glomeruli, tubular or peritubular capillary basement membrane, or larger blood vessels
  • Joints: non-erosive, non-deforming small joint involvement
  • Hematologic: Hemolytic anemia with reticulocytosis or leukopenia/lymphopenia/thrombocytopenia
  • Cardiovascular: Fibrinous pericarditis, non-bacterial endocarditis, accelerated coronary atherosclerosis in long-term disease
  • Lungs: Pleuritis, pleural effusion, interstitial fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does the mnemonic “SOAP BRAIN MD” stand for in terms of the pathologic findings in SLE?

A
  • Serositis
  • Oral Ulcers
  • Arthritis
  • Photosensitivity, Pulmonary Fibrosis
  • Blood Cells
  • Renal, Raynauds
  • ANA
  • Immunologic (Anti-Sm, Anti-dsDNA)
  • Neuropsych
  • Malar Rash
  • Discoid Rash
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the underlying pathologic mechanism in rheumatoid arthritis?

A
  • triggered by exposure to an arthitogenic (arthritis causing) antigen in a genetically predisposed individual
    • results in breakdown of immunological self-tolerance & chronic inflammatory reaction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the pathologic findings seen in the involved joints and in rheumatoid nodules of RA?

A
  • Joints:
    • non-suppurative proliferative and inflammatory synovitis
    • pannus formation: mass of inflamed synovium
    • Marked chronic papillary synovitis
    • dense chronic inflammatory infiltrate rich in plasma cells
    • inflammatory destruction of the articular cartilage and ankylosis
  • Nodule:
    • Central fibrinoid necrosis surrounded by palisade of macrophages and scattered chronic inflammatory cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the typical pathological findings in Sjogren Syndrome?

A
  • lymphocytic inflammation involving lacrimal and salivary glands
  • followed by fibrosis and gland atrophy as the disease develops
  • may also see parotid gland enlargement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the typical pathologic and clinical findings in Sjogren Syndrome?

A
  • dry eyes (keratoconjunctivitis sicca)
  • dry mouth (xerostomia)
    • resulting from autoimmune immunologically mediated destruction of lacrimal and salivary glands
  • common in middle aged women
  • some patients will also exhibit extraglandular disease:
    • synovitis
    • pulmonary fibrosis
    • peripheral neuropathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the underlying pathogenesis of Sjogren syndrome?

A
  • Unknown
  • Thought to be related to aberrant T and B cell activation in genetically susceptible individulas
    • possible trigger infection of salivary glands
17
Q

What is the underlying pathogenesis of systemic sclerosis (scleroderma)?

A
  • Unknown
  • May be related to abnormal, autoimmune response by CD4+ T lymphocytes to an unknown antigen(s)
    • release of cytokines that activate inflammatory cells and fibroblasts
  • Inappropriate humoral immunity
    • autoantibodies
18
Q

What are the typical clinical findings in Systemic Sclerosis (Scleroderma) as seen in the skin, GI tract, lungs, and musculoskeletal system?

A
  • Clinical:
    • Raynaud’s phenomenon
    • Skin: sclerotic atrophy & sclerosis, fingers→proximally/face, dystrophic calcification in the subQ fat
    • GI: esophageal fibrosis→dysmotility, dysphagia & reflux, loss of villi with malabsorption, cramps, and diarrhea (90% of patients)
    • Lungs: interstitial fibrosis
    • MSK: non-destructive arthritis, inflammatory myositis (10%)
19
Q

What are the typical pathologic findings in Systemic Sclerosis (Scleroderma) as seen in the skin, GI tract, lungs, and musculoskeletal system?

A
  • Pathologic:
    • small vessel (microvascular) damage
    • ischemic damage
    • progressive fibrosis
    • antibodies to Scl-70 (DNA topoisomerase)
20
Q

What is the underlying pathogenic defect (and pertinent genetics if appropriate) in X-linked Agammaglobulinemia (Bruton’s Aggammaglobulinemia)?

A
  • Failure of B-Cell precursors (Pro-B and Pre-B cells) to develop into mature B-cells; maturational defect due to X-linked mutation which codes for cytoplasmic Bruton tyrosine kinase (Btk)
  • X-linked - seen almost entirely in males
21
Q

What are the laboratory test findings in X-linked Agammaglobulinemia (Bruton’s Aggammaglobulinemia)?

A
  • Decreased or absent B cells in peripheral blood
  • decreased/absent Ig
  • no plasma cells
  • underdeveloped germinal centers
22
Q

What is the underlying pathogenic defect (and pertinent genetics if appropriate) in Common Variable Immunodeficiency?

A
  • Heterogenous group of disorders characterized by failure of B cells to differentiate into plasma cells
  • Sporadic and inherited forms of disease, both sexes affected equally, symptoms later onset in childhood or adolescence/young adults
  • Increased risk of Lymphomas and gastric cancers
23
Q

What are the laboratory test findings in Common Variable Immunodeficiency?

A
  • Decreased Ig production (hypogammaglobulinemia)
  • Normal numbers of B cells in blood
  • B cell lymphoid areas (germinal centers) are hyperplastic
24
Q

What is the underlying pathogenic defect (and pertinent genetics if appropriate) in Isolated IgA Deficiency?

A
  • European descent; sinopulmonary infections and diarrhea; commonly also have deficiency of IgG2 and IgG4
    • respiratory tract allergies
  • Failure of B-Cells to differentiate into IgA producing cells
25
Q

What are the laboratory test findings in IgA Deficiency?

A
  • low serum and secretory IgA levels
  • Increased risk of AI disease, anaphylactic reactions to blood transfusions
26
Q

What is the underlying pathogenic defect (and pertinent genetics if appropriate) in DiGeorge Syndrome (Thymic Hypoplasia)?

A
  • T cell deficiency due to failure of development of the 3rd and 4th pharyngeal pouches
    • Normally give rise to thymus
    • Variable loss of T-cell mediated immunity (lack of thymus)
  • Tetany (lack of parathyroid glands)
  • Congenital defects of heart and great vessels and facial abnormalities
  • Not familial, due to sporadic deletion of a gene on chromosome 22q11
27
Q

What are the laboratory test findings in DiGeorge Syndrome (Thymic Hypoplasia)?

A
  • Low levels of T-Cells in peripheral blood, T-cells in lymph nodes and spleen depleted
  • Present with fungal, viral, Pneumocystis jiroveci infections
28
Q

What is the underlying pathogenic defect (and pertinent genetics if appropriate) in Hyper-IgM Syndrome?

A
  • 70% of individuals have X-linked recessive mutations in the gene encoding CD40 ligand → can’t deliver class-switching signal
  • Pyogenic infections (low levels of opsonizing IgG)
  • Patients are able to make IgM, but are deficient in their ability to make IgG, IgA, and IgE antibodies (defect in immunoglobulin class switching)
29
Q

What are the laboratory test findings in Hyper-IgM Syndrome?

A
  • normal IgM levels, little IgG, no IgA or IgE
30
Q

What is the underlying pathogenic defect (and pertinent genetics if appropriate) in Severe Combined Immunodeficiency (SCID)?

A
  • Profound defects of both humoral and cell-mediated immunity; without hematopoietic cell transplantation, death occurs within a year.
  • Many different genetic lesions can cause SCID
  • Autosomal Recessive Disorder
  • Most common form (50-60%) is X-linked
31
Q

What are the laboratory test findings in Severe Combined Immunodeficiency (SCID)?

A
  • Reduced cytokine signaling and T cell development is markedly impaired
  • T cells and NK cells are decreased and Ab synthesis is severely impaired due to lack of T helper cells
32
Q

What is the underlying pathogenic defect (and pertinent genetics if appropriate) in Immunodeficiency with Thrombocytopenia and Eczema (Wiskott-Aldrich Syndrome)?

A
  • X-Linked Recessive Disorder with Thrombocytopenia, eczema, vulnerability to recurrent infection
  • Mutations in gene encoding Wiskott-Aldrich syndrome protein (WASP) located on short arm of x-chromosome
    • Believed to link cell membrane receptors, including antigen receptors
    • Defects in cell migration and signal transduction

Depletion in T-Cells with variable loss of cell-mediated immunity

33
Q

What are the laboratory test findings in Immunodeficiency with Thrombocytopenia and Eczema (Wiskott-Aldrich Syndrome)?

A
  • Depletion in T-Cells with variable loss of cell-mediated immunity
    • Antibody production to polysaccharide antigens is absent with low levels of serum IgM
    • IgG normal, IgA and IgE elevated
34
Q

What are the laboratory test findings in X-linked Lymphoproliferative Syndrome?

A
  • decreased antibody responses to antigens (particularly to EBV nuclear antigen)
  • impaired T-cell proliferative responses to mitogens
  • decreased NK-cell function
  • inverted CD4:CD8 ratio.
  • Some survivors of EBV infection have hypogammaglobulinemia.
  • A bone marrow biopsy can help confirm HLH.
35
Q

What is the underlying pathogenic defect (and pertinent genetics if appropriate) in X-linked Lymphoproliferative Syndrome?

A
  • Inability to eliminate EBV → severe and sometimes fatal infectious mononucleosis and B cell lymphomas
  • Most cases due to mutations in gene encoding a mlc called SLAM-associated protein (involved in activation of NK cells and T and B cells)
36
Q

What are the causes of secondary immunodeficiency?

A
  • Another underlying disorder
    • Immunosuppressive therapy
      • cytotoxic therapy for malignancy
      • treatment of autoimmune disease
      • bone marrow ablation prior to transplantation
      • treatment/prophylaxis of GVHD
      • treatment or rejection following solid organ transplant
    • Asplenia/hypospenism
    • Microbial infection (e.g. HIV/AIDS)
      • loss of CD4+ T helper lymphocytes
    • Malignancy
      • Hodgkins disease, CLL
      • Multiple Myeloma
      • Malignancy of solid tumors
    • Disorders of biochemical homeostasis:
      • diabetes
      • renal insufficiency/dialysis
      • hepatic insufficiency/cirrhosis
      • malnutrition
    • Autoimmune disease
    • Severe burn injury
    • Exposure to radiation, toxic chemicals
    • Aging
37
Q

Which type of infection are patients without a spleen at risk for? WHY?

A
  • Bacterial infection with encapsulated organisms
    • Streptococcus pneumoniae
  • VACCINATE
    • S. pneumoniae
    • H. influenzae
38
Q

What are the three ways that one could suspect a patient has an immunodeficiency?

A
  • Clinical History
    • known primary immunodeficiency
    • consider causes of secondary immunodeficiency
  • Opportunisitic Infection from a Signature Organism
    • e.g. pneumonia due to Pneumocystis jiroveci
    • e.g. Nocardia
  • Repeated Infections
39
Q

What laboratory tests would you order to assess B-cell function, T-cell function, phagocytic function, and complement?

A
  • B-Cell Function
    • Immunoglobulin levels to assess for antibody deficiencies
  • T-Cell Function
    • Flow Cytometry for cellular immunity
  • Phagocytic Function
    • CBC, Peripheral blood smear, genetic tests, test neutrophil function
  • Complement Function
    • Total serum complement (CD50)